Podcast appearances and mentions of brian bloom

This one has ALL the 80s feels! It's prom night 1988, what could go wrong? Listen and find out. This made-for-tv movie stars Christina Applegate, Matthew Perry, Brian Bloom, Tempest Bledsoe, and our favorite – Tracey Gold! We will see you in The Clubhouse! Check out our new YouTube channel, the MFTV Movie Club: Now Playing! Link: https://www.youtube.com/@MFTVMC https://made-for-tv-movie.fandom.com/wiki/Dance_%27Til_Dawn https://www.imdb.com/title/tt0094941/?ref_=fn_all_ttl_1 https://www.imdb.com/name/nm0255699/?ref_=tt_cst_t_3 https://www.imdb.com/name/nm0912308/?ref_=tt_cst_t_1 https://www.imdb.com/title/tt0097068/ https://www.imdb.com/name/nm0596959/?ref_=tt_cst_t_5 https://www.imdb.com/name/nm0001827/?ref_=tt_cst_t_4

This one has ALL the 80s feels! It's prom night 1988, what could go wrong? Listen and find out. This made-for-tv movie stars Christina Applegate, Matthew Perry, Brian Bloom, Tempest Bledsoe, and our favorite – Tracey Gold! We will see you in The Clubhouse! https://made-for-tv-movie.fandom.com/wiki/Dance_%27Til_Dawn https://www.imdb.com/title/tt0094941/?ref_=fn_all_ttl_1 https://www.imdb.com/name/nm0255699/?ref_=tt_cst_t_3 https://www.imdb.com/name/nm0912308/?ref_=tt_cst_t_1 https://www.imdb.com/title/tt0097068/ https://www.imdb.com/name/nm0596959/?ref_=tt_cst_t_5 https://www.imdb.com/name/nm0001827/?ref_=tt_cst_t_4 Check out our new YouTube channel, the MFTV Movie Club: Now Playing! Link: https://www.youtube.com/@MFTVMC

Brian Bloom, CEO of Bloom Burton & Co., gives insights into changes in the Canadian Healthcare investment landscape, the return of the generalist investor, and the rise of consumer empowerment in healthcare. Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe

This week, we're talking about the made-for-tv movie full of some of our favorite television stars of the 80s: Dance 'Til Dawn. We're also sharing a list of the most popular prom themes of the 80s, 90s and early 00s, voted on by the We Don't Wanna Grow Up community!Our InstagramOur WebsiteOur FacebookOur TikTokSupport the showWant to support the show? Become a subscriber here on Buzzsprout, or get exclusive content over on Patreon!

Take some time this week to remember your original happy hour: Saturday mornings as a kid, waking up at dawn, jumping on the couch with a bowl of chocolate cereal, turning on the ‘toons, tuning out the outside world and working your way into a sugar hangover before noon. This week we catch a movie, the San Diego Comic-Con way! Going back to the early aughts and our groups very first encounters with Comic-Con, there has always been one thing that you can count on to be great in every way… the DC Animated Movie Premiere! That's right, for many of us Comic-Con goers, the very first signs that comic books were about to hit the mainstream were watching those very same books, not just superheroes, leap from page to screen. This all started with the 2007 release of Superman: Doomsday a faithful adaptation of the Death of Superman event that saw the death and resurrection of the worlds greatest and 1st superhero. It was a glorious event that was celebrated with SWAG, exhibits, a world premier and panel. Since that awesome night, SDCC has seen many fan favs like, Batman: Year One, The Dark Knight Returns, Flashpoint Paradox, and The Killing Joke. So, let's look at SDCC's DC Animated Movie Premiere Nights through the lens of SDCC22 and the release of Green Lantern: Beware My Power with some of the movie's voice talent including AldisHodge (Black Adam), “Green Lantern John Stewart”, JimmiSimpson (Westworld), “Green Arrow”, JamieGrayHyder (Law & Order: SVU), “Hawkgirl”, BrianBloom, (The A-Team), "Adam Strange". Join Grim Shea, Marke, and Jimmy the Gent as they watch a comic book come to life in maybe the best way possible, with a SDCC crowd of fans who celebrate those themes of Saturday Morning TV!

Brian Bloom, CEO of Bloom Burton & Co., discusses the Canadian investing landscape for pharma companies, tech trends in the healthcare industry, and expectations for the upcoming Bloom Burton Award Gala. Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe

THIS IS IT! Part 2 of our Comic-Con 2022 Recap show, and it's one of our biggest shows of the year. Not only do we wrap up all of the biggest news from the event, we talk about more of our experiences and share some incredible interviews. We start with the cast and creative team from Green Lantern: Beware My Power! Hear more about this new animated film from Aldis Hodge, Jimmi Simpson, Jamie Gray Hyder, Brian Bloom, Jeff Wamester, Ernie Altbacker and John Semper. GREEN LANTERN BEWARE MY POWER IS NOW AVAILABLE ON 4K, BLU-RAY AND DIGITAL HD FROM WARNER BROS. HOME ENTERTAINMENT! We also take you to the show floor to talk with Jessica Piha-Grafstein, Head of Communications from Funko. Find out why Funko had the biggest presence on the show floor this year! We also go back outside of the con to talk to French Stewart about his time playing Harry Solomon on 3rd Rock From The Sun and the show joining the COZI TV line-up. This is also the place for a recap of all of the biggest news from Comic-Con from Marvel, DC, The Walking Dead, John Wick 4 and MUCH more! We also take a short break from con coverage to bring you interviews with the cast and creative team from the new Apple TV+ series, Surface, which is now streaming. It just doesn't get any bigger than this! Learn more about your ad choices. Visit megaphone.fm/adchoices

Brian Bloom, CEO of Bloom Burton & Co., talks about the digitization of healthcare, drawing venture capital to Canada, and the annual Bloom Burton conference. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit healthbiz.substack.com

Our coverage of October 1988's pop culture topics kicks off with a big announcement: we're on Patreon! And we've got lots of cool things planned for those who support us there! We get out our electron microscopes to peruse the two-page Columbia House spread and choose the 12 Hot Hits we're going to buy for a Cool Penny. We bring you highlights from What Now, from a rudely dismissed River Phoenix biography to a beauty queen who infiltrated a pageant! We review the reviews of A Fish Called Wanda, Joy Division's Substance, Monkey Shines, UB40's self-titled album, and more! The latest male One To Watch is...really not, but later we are introduced to FOUR lady Ones To Watch who've all had great careers. We also journey to Long Island to meet Brian Bloom, and his very-involved momager. Don't miss it!QUICK LINKS

Our coverage of October 1988's pop culture topics kicks off with a big announcement: we're on Patreon! And we've got lots of cool things planned for those who support us there! We get out our electron microscopes to peruse the two-page Columbia House spread and choose the 12 Hot Hits we're going to buy for a Cool Penny. We bring you highlights from What Now, from a rudely dismissed River Phoenix biography to a beauty queen who infiltrated a pageant! We review the reviews of A Fish Called Wanda, Joy Division's Substance, Monkey Shines, UB40's self-titled album, and more! The latest male One To Watch is...really not, but later we are introduced to FOUR lady Ones To Watch who've all had great careers. We also journey to Long Island to meet Brian Bloom, and his very-involved momager. Don't miss it!Visual Aids

In the third episode of our fifth season, our host Peter Brenders talks with Brian Bloom, Chairman & CEO of Bloom Burton & Co., about the investment climate, hot sectors for healthcare investment and the future of biotech. Get on the email list at healthbiz.substack.com

We're back to TEEN LIFE topics, now in the April 1988 issue! Christina Kelly gets a first-person account from a man whose friend died of AIDS as a teen. Karen Catchpole demystifies what it's actually like to date a rock star, killing some Beastie Boys crushes in the process. Karen then dares to tell the truth about boys' bodies -- not just the parts in their boxer shorts, though that is admittedly what we're mostly interested in. And Catherine Gysin prepares readers for how their lives might change after their parents' divorce. Christina returns with the Short Short Story "What Sudie Didn't Tell Me." On The Road takes a trip to Austin (a place all your co-hosts have lived and loved!). Body Talk moves from Fashion to Teen Life, and with it our comments on its reporting on pap smears, golf, and cross training. Help has some truly wild questions we must pray are fake before closing things out with What He Said: "What do you think of girls who make the first move?" Visual Aids

How can you find the courage to live life on your terms? Tom explores Principle 1: You are more than enough, be yourself. Show your authentic self to attract what you desire. Together with guest Brian Bloom, a relationships coach, they discuss how we can discover and unleash our authentic selves.Selected Links· Connect with Brian Bloom Website | LinkedIn· Connect with Tom Marshall Website | LinkedIn· Landmark education· Non-Violent Communication workshop series, Marshall Rosenberg· Burning Man· Nowhere, regional Burning Man in SpainShow NotesTom’s personal story about why he created this principle. [1:25]Challenges with the principle that are explored in this episode. [3:50]Introduction to Brian Bloom. [4:27]What does authenticity mean to Brian? [05:40]How Brian realised he’d succeeded by the societal scripts but was incredibly dissatisfied. [06:45]Brian shares how he redefined the meaning of divorce. [08:45]How does Brian now relate to his ex-wife? [11:20] Not everyone will understand your life choices and it’s not your responsibility to make them. Don’t bow to the expectations of others. [13:00]How Brian explored his sexuality and alternative relationship structures. [14:10]Thank people who express concern about your life choices. [15:55]How does Brian find the courage to be his authentic self? [17:15]How showing his authentic self has helped Brian attract what he desires. [21:35]Surrounding yourself with people like you gives you permission to be more self-expressed. [22:10]Why Brian deserves the “purple heart of weirdness” medal. [23:55]How Brian invests in finding his people by being his authentic self [25:50]Brian shares his experiences of radical inclusion at Burning Man, an experiment in creating community. [27:45]Unconditionally accepting people around you helps them be authentic. [29:03]Brian shares his exploration of wearing dresses. [30:02]“Until you try stuff on, you don’t really know who you are.” [32:03]What advice Brian has for early career professionals who have trouble being fully authentic [33:11]Brian shares how he “threw his hat over the fence” to overcome the challenge of moving to Europe. [35:21]Always accept free samples. [37:51]How to use social accountability to live more authentically [39:32] “How much energy are you going to waste trying to live up to others’ expectations instead of exploring your own?” [42:15]Summary of the episode. [42:27]How Brian’s story challenges us. [43:49]

Hunteeeee…Season 3 starts with ‘Sticky Vibes.' Queen Shanshan interviews her two good friends who decided to have their first child through surrogacy. Nick and Brian Bloom, a gay couple in Los Angeles shares their eye opening journey in having their first child by surrogacy. What were the challenges and the rewards they experienced? Why did they go through the tough road of surrogacy vs. adoption and what did they learn from it? What were the costs involved and how did they pick the person who was to be their surrogate? What are the values they plan to instill in their baby girl as she grows into womanhood? Additionally, the recent mass shootings that shocked the nation are discussed and explored. If you are ready to build your family and you don't know were to start, contact Nick and Brian Bloom at FMLY.INC  and they will help individuals with surrogacy consulting. Headquartered in Los Angeles, FMLY Inc supports anyone looking to start a family through non-traditional methods and eliminating unnecessary costs along the way. Contact them at https://www.fmlyinc.com  IG: @Fmlyinc     Twitter: @fmlyinc Thank you to our sponsors: RB Paving and Landscaping                   https://beltranpavingandlandscape.com Ma's Italian Kitchen https://www.masitaliankitchen.com ShanInsure      https://shaninsure.com   Instagram                https://www.instagram.com/queenshanshan Twitter                  https://twitter.com/a_broad_prod? Facebook            https://www.facebook.com/abroadproductions Website  https://abroadproductions.com Podcast Website:  https://abroadpodcasts.com/ REMINDER! Sign up for my new BLOG and Newsletter every week for new updates, wig alerts, Hot Tea to be spilt and just some fun stuff that will brighten up you day. Thanks again for tuning into and listening to A BROAD! REMINDER- Set your “notification” button on to alert you to listen new episodes that are live!  

The stars of the upcoming 'Wolfenstein II: The New Colossus' stop by to talk about the game's timely subject matter, offer their thoughts on the current controversy around the game and, most importantly, tease how much fun and craziness they've crammed into the game; Eddie & Pat argue over Cuphead and how to drink coffee correctly

Today on the Morphin Grid Jake and Josh watch "The Mirror Of Regret". Neither of us are sure what happened but we were full on Morphin Grid Classic today. We talked about Brian Bloom, Zoo Books, and Crispy M&Ms for way longer than intended. Website: MorphinGrid.tumblr.com, Email: littleidiots.morphingrid@gmail.com, Twitter: @morphingrid, Facebook: facebook.com/themorphingrid.

Coming up on this week’s show: Pfizer partners with a Canadian biotech on a new therapeutic antibody discovery project, Quark Ventures keeps rolling out the dollars and Bloom Burton & Co. to host its first award gala. We have all this and more on this week’s Biotechnology Focus Podcast. Welcome to another episode of Biotechnology Focus Podcast. I’m your host Shawn Lawrence, here to give you a rundown of this week’s top stories on the Canadian biotech scene. Story 1 Our first story this week takes us to TORONTO, ON- where Canadian healthcare investment banking firm Bloom Burton & Co., has announced that it will host its inaugural Award Gala at the Four Seasons Hotel in Toronto, ON on September 14, 2017. As part of this special event, the firm also plans to recognize Canada’s Healthcare Industry biggest star with its newly minted ‘Bloom Burton Award.’ According to the firm, it plans to bestow this award annually to an individual scientist, inventor, executive, entrepreneur, industry leader, or policy maker who has made the greatest impact in Canada’s innovative healthcare industry. Bloom Burton & Co president Brian Bloom commented that it’s time to celebrate those who advance medical science, attract and provide risk capital, launch new products and companies on the world stage or announce significant monetization events, with The Bloom Burton Award celebrating today’s finest. Nominees will all healthcare subsectors including biotechnology, pharmaceutical, medical device, diagnostic/imaging, research instrumentation, consumer health, healthcare services or healthcare IT sectors. The judges include respected international leaders in healthcare investment, entrepreneurship and journalism. Among them are Karen Bernstein, Co-Founder and Chairman, BioCentury Inc.; Terrence Connolly, Executive Director, Global Alliances and Business Development, Celgene Corporation; Carl Gordon, Partner and Co-Head of Global Private Equity, OrbiMed Advisors; Andrew Hack, Chief Financial Officer, Editas Medicine; Oleg Nodelman, Founder and Managing Director, EcoR1 Capital; Melinda Richter, Head of Johnson & Johnson Innovation, JLABS; and Avik Roy, Opinion Editor, Forbes; President, The Foundation for Research and Equal Opportunity. narrowed list of three finalists will be announced at the Bloom Burton & Co. Healthcare Investor Conference, taking place May 1-2, 2017. For more information, visit www.bloomburton.com. Story 2 Vancouver-based ProNAi Therapeutics has changed its corporate name to Sierra Oncology. According to company president and CEO Dr. Nick Glover, the name change is about better reflecting the company’s oncology focus, specifically its pipeline of therapies that target the DNA Damage Response (DDR) network. The company believes there is a significant opportunity for therapeutics that target the DDR network to have broad potential in the treatment of cancer. Additionally, the company has successfully in licensed sponsorship of two ongoing Phase 1 clinical trials evaluating its Checkpoint kinase 1 (Chk1) inhibitor, SRA737, from the Cancer Research UK Centre for Drug Development, where it was discovered and initially developed. In accordance with the license agreement for SRA737, a $2.0 million fee is due to CRT Pioneer Fund LP for the achievement of this milestone. According to Glover, SRA737 targets Chk1, a key cell cycle checkpoint and central regulator of the DDR network. The company is concurrently also conducting preclinical research evaluating SRA737 in combination with other DDR agents including PARP inhibitors and Sierra Oncology’s proprietary Cdc7 inhibitor, SRA141, as well as with immuno-oncology therapeutics. Finally, as of January 10th, company shares started trading on the NASDAQ under the symbol ‘SRRA. Story 3 In Venture capital news, Canadian VC-firm Quark Venture Inc. along with its partner, Chinese investment bank GF Securities say they are investing US$25 million in Microbion Corp. through the firm’ss $656-million Global Health Sciences Venture Fund. Microbion, co-located in Vancouver, BC and Bozeman, MT, is a clinical stage biopharmaceutical company specializing in the treatment of antibiotic-resistant infections. Its lead compound, MBN-101, is the first in a new class of products to treat infections by attacking both bacteria and related microbial biofilms. Among other advancements, the investment will go towards enabling Microbion in the initiation and completion of a Phase 1B/2A study in diabetic foot ulcer infections, the study will evaluate both safety and efficacy endpoints including eradication of infections and of biofilms. In 2016, the U.S. Food and Drug Administration (FDA) granted MBN-101 Qualified Infectious Disease Product (QIDP) and Fast Track designations for adjunctive treatment of moderate and severe diabetic foot ulcer infections. According to Karim Lalji, chairman and CEO of Microbion Pharma Corp, and former Simon Fraser University graduate, that in addition to proceeding with the Phase 1B/2A study, the investment will also allow the company to continue a Phase 2a trial in orthopaedic infections as well as to advance its development of an inhaled formulation of MBN-101 to treat cystic fibrosis related infections. Story 4 Looking at our top R&D news story, Canadian and Australian prostate cancer researchers say they have discovered a key piece in the genetic puzzle of why men born with a BRCA2 mutation may develop aggressive localized cancers that resist treatment and become lethal for up to 50 per cent of patients within five years. Their findings, published online in Nature Communications, show that BRCA2-associated tumours are already pre-set to be aggressive, even before treatment. This is because the genes normally involved in regulating cell growth and division are abnormal in the BRCA2-associated cancers right from the get-go and therefore are resistant to therapy right up front, says co-principal investigator Dr. Robert Bristow, clinician-scientist at Princess Margaret Cancer Centre, University Health Network. He talks about the research in the following audio provided by UHN: Insert audio from video…. https://www.youtube.com/watch?v=dXlntpaWtaI In the published study, Dr. Bristow and co-principal investigators Dr. Paul Boutros at the Ontario Institute for Cancer Research, and prof. Gail Risbridger at Monash University, Melbourne, Australia, compared 15 patients with BRCA2-inherited prostate cancer with 500 prostate cancer patients from the general population with non-inherited (sporadic) prostate cancer. In the related study of 500 tumours from Canadian men with non-inherited prostate cancer also published in Nature, Drs. Bristow and Boutros analyses led to the discovery of a new genetic fingerprint that identifies when curable disease may turn aggressive. Although BRCA2-inherited disease affects less than two per cent of men with prostate cancer, Dr. Bristow says the research sets the stage to rethink ways to use other drugs differently to personalize treatment for more men. The next steps are to explore the use of novel therapies to offset the BRCA2-associated aggressiveness earlier on in the treatment of these men and improve survival in an otherwise lethal tumour, and he says this might include different types of chemotherapy or the use of molecular-targeted drugs that specifically target the changes associated with BRCA2 mutation. Funding for this reasearch was provided by the Movember Foundation through Prostate Cancer Canada, the Ontario Institute for Cancer Research, CPC-GENE, and The Princess Margaret Cancer Foundation. Story 5 Our final story this week sees drug giant Pfizer entering into a multi-year collaboration with Vancouver-based AbCellera Biologics, Inc. As part of the collaboration, the two sides hope to generate lead antibody candidates using AbCellera’s mAb discovery platform, specifically AbCellera plans to apply its proprietary monoclonal antibody (mAb) screening platform to attempt to discover function-modulating antibodies against undisclosed membrane protein targets. Carl Hansen, founding CEO of AbCellera commented that his company is increasingly being recognized as a leader in high-performance antibody discovery, and this deal validates this fact. He explains that what makes his company’s platform unique is that it is able to screen natural immune repertoires with unparalleled depth unlocking the most challenging discovery programs. Moroever he says this partnership not only reinforces his company’s business strategy but also brings an added benefit through the ability to work closely with the innovative team at Pfizer. Under the terms of the agreement, AbCellera will receive an upfront payment and research support, and will be eligible to receive up to approximately $90 million in contingent milestone payments, as well as tiered mid-to-low single digit royalty payments based on Pfizer’s development and commercialization of antibodies that may be generated under this collaboration. Further terms of the agreement are not disclosed. With that we’ve come to the end of another program. A big thanks to our technical director and production manager Laskey Hart and to the rest of the Biotechnology Focus research team. Be sure to check back next week to see all the latest news happening on the Canadian biotech scene. And if you like our show, you can also listen to past episodes online via our podcast portal at www.biotechnologyfocus.ca .We’re also always looking for your feedback, story ideas and suggestions so we’d love to hear from you. Simply reach out to us on twitter: @BiotechFocus or by email Biotechnology_focus@promotive.net. For all of us here at Biotechnology Focus, thank you for listening.

Home or away, Brian Bloom is recognized for his wildly successful conference and boutique investment bank. With a mission to uncover and cultivate Canadian life sciences companies through scientific focus and range of services, Bloom Burton & Co., which he co-founded in 2008, has risen swiftly to be profitable and globally unique. And its Bloom Burton Healthcare Investor Conference achieved actual hockey stick growth since it broke onto the Canadian biotech scene 5 years ago. But hockey and cheerleaders do not go together. Brian’s knowledge of the Canadian biotech scene, and his seat on umpteen boards, leads him to a frank, no-apologies stance on the industry.  

Brian Bloom from AJEX talks about their annual parade, comedian Ashley Blaker on his current synagogue tour and on Round Table we discuss Boris Johnson's visit to Israel and the EU decision to label goods made in West-Bank settlements.

BONUS EPISODE, PEOPLE! All our Dancing with the "Star" chatter, PLUS *BREAKING* Randy Quaid, Justin Bieber and Brian Bloom news! Please enjoy this special BONUS EPISODE of the poorly edited $#@%-show you know and occasionally listen to for two minutes before turning on Fresh Air!

Brian Bloom had an early interest in acting, including appearing in several commercials as a child, but made his big break in the Sergio Leone film Once Upon a Time in America. From there, he was offered the role of Dusty Donovan in the hit soap opera As the World Turns, which he played for several years. During that run, Bloom became the youngest winner of a Daytime Emmy Award in the category of Outstanding Young Leading Man during the 12th Daytime Emmy Awards show for his performance on the series. Despite his success, he soon grew tired of the scheduling involved in that field and eventually left the series to star in several television movies and myriad guest appearances. Brian played private mercenary bad guy "Pike" in the 2010 movie The A-Team, which he also co-wrote with Carnahan, who directed the 20th Century Fox feature based on the popular television series. Brian also attended the Sheriff's Academy and served as a Reserve Deputy with the Orange County Sheriff's Department from 2001 - 2011. He is a certified self defense expert and a Sifu of a rarefied street lethal modern Self Defense System called "Bojuka". He has participated in countless no holds barred combat seminars and taught use of force techniques to law enforcement, military and private security worldwide. Brian is presently cast in a number of voiceover parts, both in video games as well as direct-to-video projects. He has been working for the past several years on Warner Bros. Mad Max game, designing the characters fighting style and doing the motion capture and performance capture for its lead character incorporating his martial arts to create the characters spec ops-based combat mechanics. Brian has grown into one of the most respected and seasoned actors in the gaming and voice over industry. He was part of the development team working closely with infinity Ward to not only develop the story for Activision's Call of Duty Ghosts, but also voiced one of its four lead characters, Ghost Team member, Keegan P. Russ. He has contributed his voice to every call of duty game since CoD III to the present. Brian is continuing his work with developer Infinity Ward on a future and highly secretive upcoming version of Call of Duty working with their story team to bring the franchise into a whole new era. Brian plays Matt Horner in the wildly popular StarCraft franchise made by the developers of World of Warcraft. His portrayal of Gotham's most menacing gangster "black mask" will no doubt recur in upcoming Batman titles under the Warner Bros. banner in the Arkham universe. He portrays BJ Blascowicz in "Wolfenstein the New Order”, a critically acclaimed and highest selling titles is said to have been a key component in saving the first person shooter genre and launching it into next gen gaming consoles and PCs with a memorable and dramatic take on the classic and prototypical hero character. Brian is working on the third iteration of the internationally popular game Dragon age where he plays it's most beloved character Varric Tethras. Brian is a prolific motion capture and performance capture performer who brings 30 years of television and motion picture experience to the arena of Videogames both in front of and behind the camera and microphone consulting on story and narrative in various capacities on numerous successfully received and yet to be released IP's and titles. Brian works alongside military contractors and new media companies helping coordinate shared technologies and mutually beneficial interests helping both sides integrate their common ground to innovate products and services integral to the growth of both industries. He has recently formed a production company, writing and developing several original television and film properties. His screenplay "hacked" and television pilot "pyramid" among them.